Clinical Scorecard: Understanding ROHHAD Syndrome: An Interdisciplinary Approach to Management
At a Glance
Category
Detail
Condition
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and potential association with neuroendocrine tumors (ROHHAD syndrome)
Key Mechanisms
Target Population
Care Setting
Key Highlights
Median age at onset: 3.3 years
Key driver of complexity: Central hypoventilation leading to tracheostomy and long-term ventilation
Multisystem endocrine involvement with metabolic instability
Common neurodevelopmental concerns and behavioral dysregulation
Significant mortality risk, primarily due to cardiorespiratory arrest
Emerging evidence of autoimmune mechanisms in some patients
Guideline-Based Recommendations
Diagnosis
Clinical diagnosis based on exclusion of alternative conditions
Consider genetic counseling and testing due to the unclear etiology
Management
Supportive and symptomatic management requiring interdisciplinary coordination
Early recognition of neuroendocrine tumors in management strategies
Monitoring & Follow-up
Proactive vigilance for respiratory and metabolic complications
Risks
High risk of mortality due to cardiorespiratory arrest
Patient & Prescribing Data
Children with confirmed ROHHAD syndrome
Management strategies are primarily supportive and require specialized care
Clinical Best Practices
Integrated care pathways to address multisystem involvement
Early recognition of symptoms for better outcomes
Ongoing collaboration among various specialties
Awareness of potential neuroendocrine tumors in patient management
by Anna Mercante, Annalisa Salerno, Anna Marinetto, Anna Santini, Benedetta Tascini, Alessia Raffagnato, Valentina De Tommasi, Antuan Divisic, Franca Benini
